Choi; Je-Min

Patent Applications and Registrations

Patent applications and USPTO patent grants for Choi; Je-Min.The latest application filed is for "crispr-cas-based composition for gene correction".

Company Profile

7.6.11

Choi; Je-Min - Seoul KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical composition for preventing and treating transplant rejection Grant 11,351,224 - Choi , et al. June 7, 2	2022-06-07
Crispr-cas-based Composition For Gene Correction App 20220009968 - CHOI; Je-Min ; et al.	2022-01-13
Composition For Preventing Or Treating Autoimmune Disease Based On Lrr Domain Of Nlrx1 Protein App 20220009978 - CHOI; Je-Min ; et al.	2022-01-13
Peptides having effects of preventing or treating central nervous system diseases and pharmaceutical compositions for preventing or treating central nervous system diseases containing same as active ingredient Grant 11,053,295 - Choi , et al. July 6, 2	2021-07-06
Pharmaceutical Compositions For Preventing Or Treating Pulmonary Metastasis Of Cancer Including Chi3l1 Inhibitor As Active Ingredient App 20210046151 - CHOI; Je-Min ; et al.	2021-02-18
Skin-penetrating peptide and method for using same Grant 10,858,395 - Choi , et al. December 8, 2	2020-12-08
Peptide having anticancer activity, and pharmaceutical composition and dietary supplement composition for preventing and treating cancer, both of which contain same as active ingredient Grant 10,611,797 - Kim , et al.	2020-04-07
Pharmaceutical Composition For Preventing And Treating Transplant Rejection App 20200054713 - CHOI; Je-Min ; et al.	2020-02-20
Pharmaceutical Composition For Preventing Or Treating Inflammatory Respiratory Disease Containing Fusion Protein In Which Cell-p App 20200023036 - CHOI; Je-Min ; et al.	2020-01-23
Peptides Having Effects Of Preventing Or Treating Central Nervous System Diseases And Pharmaceutical Compositions For Preventing App 20190202888 - CHOI; Je-Min ; et al.	2019-07-04
Skin-penetrating Peptide And Method For Using Same App 20190055285 - CHOI; Je-Min ; et al.	2019-02-21
Cell penetrating peptide and method for delivering biologically active substance using same Grant 9,969,774 - Choi , et al. May 15, 2	2018-05-15
Peptide Having Anticancer Activity, And Pharmaceutical Composition And Dietary Supplement Composition For Preventing And Treating Cancer, Both Of Which Contain Same As Active Ingredient App 20180086788 - KIM; Chul Geun ; et al.	2018-03-29
Cell Penetrating Peptide And Method For Delivering Biologically Active Substance Using Same App 20170057997 - CHOI; Je-Min ; et al.	2017-03-02
Methods for treating rheumatoid arthritis using a CTLA-4 fusion protein Grant 7,723,299 - Lee , et al. May 25, 2	2010-05-25
Methods for fusion polypeptide delivery into a cell App 20070105775 - Lee; Sang-Kyou ; et al.	2007-05-10
DNA/RNA transduction technology and its clinical and basic applications App 20060099677 - Lee; Sang-Kyu ; et al.	2006-05-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.